Profil
Lisa Koch-Hulle worked as the Head of Regulatory Affairs at Alliance Pharmaceutical Corp.
from 1991 to 2002.
She then worked as the VP of Regulatory Affairs & Clinical Operations at La Jolla Pharmaceutical Co. before becoming the Vice President of Regulatory Affairs at Light Sciences Oncology, Inc. from 2009 to 2012.
Ms. Koch-Hulle received an undergraduate degree from San Diego State University.
Ehemalige bekannte Positionen von Lisa Koch-Hulle
| Unternehmen | Position | Ende |
|---|---|---|
Alliance Pharmaceutical Corp.
 Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | General Counsel | 01.01.2002 |
| LA JOLLA PHARMACEUTICAL COMPANY | General Counsel | - |
Light Sciences Oncology, Inc.
 Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Light Sciences Oncology, Inc. operates as a pharmaceutical company. It develops Aptocine for the treatment of solid tumors as well as other indications such as benign prostatic hyperplasia. The company was founded in 1994 and is headquartered in Bellevue, WA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lisa Koch-Hulle
| San Diego State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Light Sciences Oncology, Inc.
Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Light Sciences Oncology, Inc. operates as a pharmaceutical company. It develops Aptocine for the treatment of solid tumors as well as other indications such as benign prostatic hyperplasia. The company was founded in 1994 and is headquartered in Bellevue, WA. | Health Technology |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Alliance Pharmaceutical Corp.
Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | Health Technology |